A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
出版年份 2020 全文链接
标题
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-08-13
DOI
10.3389/fphar.2020.01214
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
- (2020) Yingzhen Du et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
- (2020) Dipak Panigrahy et al. CANCER AND METASTASIS REVIEWS
- SnapShot: COVID-19
- (2020) Blake Oberfeld et al. CELL
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
- (2020) Jean-Laurent Casanova et al. CELL
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 update: Covid-19-associated coagulopathy
- (2020) Richard C. Becker JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Kawasaki-like disease: emerging complication during the COVID-19 pandemic
- (2020) Russell M Viner et al. LANCET
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
- (2020) Yuan Liu et al. NATURE
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 productively infects human gut enterocytes
- (2020) Mart M. Lamers et al. SCIENCE
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Clinical features of covid-19
- (2020) Pauline Vetter et al. BMJ-British Medical Journal
- COVID-19 cytokine storm: the interplay between inflammation and coagulation
- (2020) Ricardo J Jose et al. Lancet Respiratory Medicine
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
- (2020) Celestino Sardu et al. Journal of Clinical Medicine
- Mounting clues suggest the coronavirus might trigger diabetes
- (2020) Smriti Mallapaty NATURE
- Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
- (2020) Colin D. Funk et al. Frontiers in Pharmacology
- Clinical and pathological investigation of patients with severe COVID-19
- (2020) Shaohua Li et al. JCI Insight
- As a potential treatment of COVID-19: Montelukast
- (2020) Cihan Fidan et al. MEDICAL HYPOTHESES
- The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast
- (2020) Muhammad Qutayba Almerie et al. MEDICAL HYPOTHESES
- Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males
- (2017) Simona Pace et al. JOURNAL OF CLINICAL INVESTIGATION
- Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT2 receptor
- (2015) Valérie Capra et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Montelukast reduces sepsis-induced lung and renal injury in rats
- (2014) Ahmed E. Khodir et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Pivotal Role of 5-Lipoxygenase Pathway in Lung Injury After Experimental Sepsis
- (2013) Ana Paula T Monteiro et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation
- (2011) Christian D. Sadik et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity
- (2008) F. Tahan et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport
- (2008) Michael P. W. Moos et al. FASEB JOURNAL
- ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma
- (2008) C. Pergola et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started